Quantcast

Duodenal Cancer Global Clinical Trials Review, H1, 2014

June 2, 2014

LONDON, June 2, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

Duodenal Cancer Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/duodenal_cancer_global_clinical_trials_review_h1_2014.html

Duodenal Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData’s clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2014″ provides data on the Duodenal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Duodenal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Duodenal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Introduction 5
Duodenal Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase 16

In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Duodenal Cancer 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Duodenal Cancer Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Silence Therapeutics AG 26
Clinical Trial Overview of Silence Therapeutics AG 26
Oncothyreon Inc. 27
Clinical Trial Overview of Oncothyreon Inc. 27
F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of Top Institutes / Government 29
National Cancer Institute 29
Clinical Trial Overview of National Cancer Institute 29
Wakayama Medical University 30
Clinical Trial Overview of Wakayama Medical University 30

Nagoya University 31
Clinical Trial Overview of Nagoya University 31
Seoul National University Hospital 32
Clinical Trial Overview of Seoul National University Hospital 32
The University of Tokyo 33
Clinical Trial Overview of The University of Tokyo 33
Thomas Jefferson University 34
Clinical Trial Overview of Thomas Jefferson University 34
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 35
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 35

Odense University Hospital 36
Clinical Trial Overview of Odense University Hospital 36
Weill Cornell Medical College 37
Clinical Trial Overview of Weill Cornell Medical College 37
USC Norris Comprehensive Cancer Center 38
Clinical Trial Overview of USC Norris Comprehensive Cancer Center 38
Five Key Clinical Profiles 39
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 58

List of Tables

Duodenal Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 6
Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Duodenal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 15
Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Duodenal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 20
Duodenal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21

Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics AG, 2014* 26
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncothyreon Inc., 2014* 27
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 28
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 29
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wakayama Medical University, 2014* 30
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2014* 31
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 32
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014* 33
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 34
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014* 35
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 36
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014* 37
Duodenal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris Comprehensive Cancer Center, 2014* 38

List of Figures

Duodenal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 15
Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 56

Read the full report:
Duodenal Cancer Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/duodenal_cancer_global_clinical_trials_review_h1_2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus